Tevogen Bio Holdings (TVGN) Payables (2021 - 2026)
Tevogen Bio Holdings (TVGN) reported Payables of $5.4 million for Q1 2026, down 13.71% on a YoY basis from $6.3 million in Q1 2025, and up 9.19% quarter-over-quarter from $5.0 million in Q4 2025.
Tevogen Bio Holdings (TVGN) Payables (2021 - 2026) Analysis & Trends
Tevogen Bio Holdings has reported Payables for 6 years, with the latest figure at $5.4 million in Q1 2026.
- For the quarter ending Q1 2026, Payables fell 13.71% year-over-year to $5.4 million; the trailing twelve-month figure through Mar 2026 stood at $5.4 million (down 13.71% YoY), and the FY2025 full-year result was $5.0 million, down 27.15% from the prior year.
- Payables for Q1 2026 stood at $5.4 million, up from $5.0 million in the prior quarter.
- The five-year high for Payables was $84.1 million in Q4 2023, with the low at $128999.0 in Q1 2022.
- Historically, Payables has averaged $8.6 million across 5 years, with a median of $5.0 million in 2025.
- Annual changes were most pronounced in 2023 — Payables jumped 39875.66% — and 2024, when it slumped 91.86%.
- Tevogen Bio Holdings' Payables stood at $210454.0 in 2022, then jumped by 39875.66% to $84.1 million in 2023, then tumbled by 91.86% to $6.9 million in 2024, then fell by 27.15% to $5.0 million in 2025, then advanced by 9.19% to $5.4 million in 2026.
- The last three Payables figures came in at $5.4 million (Q1 2026), $5.0 million (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 8.69 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 34.55 Mn |
| 10 | Tevogen Bio Holdings | 182.04 Mn | 181.35 Mn | - | 5.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.45 Mn |
| Dec 31, 2025 | 4.99 Mn |
| Sep 30, 2025 | 4.96 Mn |
| Jun 30, 2025 | 5.89 Mn |
| Mar 31, 2025 | 6.32 Mn |
| Dec 31, 2024 | 6.85 Mn |
| Sep 30, 2024 | 7.49 Mn |
| Jun 30, 2024 | 8.32 Mn |
| Mar 31, 2024 | 6.86 Mn |
| Dec 31, 2023 | 84.13 Mn |
| Sep 30, 2023 | 1.63 Mn |
| Jun 30, 2023 | 1.32 Mn |
| Mar 31, 2023 | 485,074.00 |
| Dec 31, 2022 | 210,454.00 |
| Sep 30, 2022 | 171,783.00 |
| Jun 30, 2022 | 179,234.00 |
| Mar 31, 2022 | 128,999.00 |
| Dec 31, 2021 | 39,375.00 |